Hao Duan Selected Research

Hao Duan Research Topics

Disease

15	Neoplasms (Cancer) 06/2022 - 06/2014
7	Glioma (Gliomas) 01/2022 - 07/2017
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
3	Ischemic Stroke 04/2017 - 03/2010
3	Esophageal Squamous Cell Carcinoma 12/2016 - 11/2015
2	Osteoporosis 01/2022 - 12/2021
2	Brain Neoplasms (Brain Tumor) 06/2020 - 09/2018
2	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 11/2016 - 06/2014
2	Stroke (Strokes) 01/2012 - 03/2010
1	Medulloblastoma 07/2022
1	Postoperative Nausea and Vomiting (PONV) 06/2022
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Vascular Remodeling 12/2021
1	Postmenopausal Osteoporosis 12/2021
1	Hallux Valgus 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Ischemia 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Intracranial Hypertension 09/2018
1	Lymphoma (Lymphomas) 09/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2017
1	Enterovirus Infections 01/2017
1	Carcinoma (Carcinomatosis) 05/2016
1	Esophageal Neoplasms (Esophageal Cancer) 05/2016
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Inflammation (Inflammations) 05/2016
1	Lymphatic Metastasis 05/2016
1	Pain (Aches) 10/2015
1	Neuralgia (Stump Neuralgia) 10/2015

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
3	AlbuminsIBA 01/2021 - 07/2017
3	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 01/2012
2	Fluorescein (Funduscein)FDA LinkGeneric 07/2022 - 09/2018
2	Fibrinogen (Factor I)FDA Link 01/2021 - 07/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	C-Reactive ProteinIBA 01/2021 - 05/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	Serum AlbuminIBA 07/2017 - 05/2016
1	HydrogelsIBA 06/2022
1	dolasetron (Anzemet)FDA Link 06/2022
1	Analgesics (Analgesic Drugs)IBA 06/2022
1	17- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one (DMAA)IBA 01/2021
1	Combined Antibody TherapeuticsIBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Circulating Tumor DNAIBA 06/2020
1	Temozolomide (Temodar)FDA LinkGeneric 06/2020
1	Long Noncoding RNAIBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	PlasminogenIBA 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	TransferasesIBA 11/2019
1	Untranslated Regions (Untranslated Region)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Neuroprotective AgentsIBA 04/2017
1	NeuroglobinIBA 04/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	KinesinsIBA 12/2016
1	NucleotidesIBA 11/2016
1	Tumor Biomarkers (Tumor Markers)IBA 05/2016
1	Carcinoembryonic AntigenIBA 05/2016
1	Indicators and Reagents (Reagents)IBA 05/2016
1	squamous cell carcinoma-related antigenIBA 05/2016
1	Type 1 Galanin ReceptorIBA 10/2015
1	Galanin Receptors (Galanin Receptor)IBA 10/2015
1	GalaninIBA 10/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2014
1	Phosphotransferases (Kinase)IBA 06/2014
1	Platelet Membrane GlycoproteinsIBA 01/2012
1	Integrin beta3 (GPIIIa)IBA 01/2012

Therapy/Procedure

7	Therapeutics 12/2021 - 06/2014
3	Immunotherapy 01/2022 - 01/2021
2	Ovariectomy (Oophorectomy) 01/2022 - 12/2021
2	Operative Surgical Procedures 01/2019 - 09/2018
1	Thoracotomy 06/2022
1	Transplantation 01/2022
1	Molecular Targeted Therapy 01/2022
1	Lasers (Laser) 12/2021
1	Drug Therapy (Chemotherapy) 06/2020
1	Radiotherapy 01/2018
1	Craniotomy 01/2018
1	Esophagectomy 11/2015
1	Neoadjuvant Therapy 11/2015
1	Contraindications 03/2010